1. Fahey, J.L., Ware, A.G. and Seegers, W.H. Stability of prothrombin and Ac-globulin in stored human plasma as influenced by conditions of storage. Am. J. Physiol. 1948; 154:122-133.

2. Ware, A.G., Fahey, J.L. and Seegers, W.H. Platelet extracts, fibrin formation and interaction of purified prothrombin and thromboplastin. Am. J. Physiol. 1948; 154:140-147.

3. Fahey, J.L., Olwin, J.H. and Ware, A.G. Effect of Dicumarol on Ac-globulin and prothrombin activity. Proc. Soc. Exp. Biol. and Med. 1948; 69:491-494.

4. Fahey, J.L., Ware, A.G. and Seegers, W.H. The stability of Ac-globulin and of prothrombin in citrated human plasma. Surg. Gyn. and Obst. 1949; 88:370-372.

5. Olwin, J.H. and Fahey, J.L. Ac-globulin levels in thromboembolism. Am. Surg. 1950; 132:443-449.

6. Seegers, W.H., McClaughry, R.E. and Fahey, J.L. Some properties of purified prothrombin and its activation with sodium citrate. Blood. 1950; 5:421-433.

7. Fahey, J.L. Effect of ACTH on whole blood coagulability. Proc. Soc. Exp. Biol. and Med. 1951; 77:491-494.

8. Fahey, J.L., Leonard, E., Churg, J. and Godman, G. Wegener’s granulomatosis. Am.J. Med. 1954; 17:168-179.

9. Potter, M., Fahey, J.L. and Pilgrim, H.I. Abnormal serum protein and bone destruction in a transmissible mouse plasma cell neoplasm (Multiple Myeloma). Proc. Soc. Exp. Biol. and Med. 1957; 94:327-333.

10. Fahey, J.L. Toxicity and blood ammonia rise resulting from intravenous amino acid administration in man: The protective effect of L-arginine. J. Clin. Invest. 1957; 36:1647-1655.

11. Fahey, J.L., Nathans, D. and Rairigh, D. Effect of L-arginine on elevated blood ammonia levels in man. Am. J. Med. 1957; 23:860-869.

12. Fahey, J.L., Perry, R.S. and McCoy, P.F. Blood ammonia elevation and toxicity from intravenous L-amino acid administration to dogs: The protective role L-arginine. Am. J. Physiol. 1958; 192:311-317.

13. Nathans, D., Fahey, J.L. and Ship, A.G. Sites of origin and removal of blood ammonia formed during lysine infusion: Effect of L-arginine. J. Lab. and Clin. Med. 1958; 51:124-133.

14. Lane, M., Fahey, J.L., Sullivan, R.D and Zubrod, C.G. The comparative pharmacology in man and the rat of the ribflavin analogue U-2112. J. Pharm. and Exp. Therapeutics 1958; 112:315-326.

15. Fahey, J.L., McCoy, P.F. and Goulian, M. Chromatography of serum proteins in normal and pathologic sera: The distribution of protein-bound carybohydrate and cholestrol, siderophilin, thyroxin-binding protein, B12-binding protein, alkaline and acid phosphatases, ratio-iodinated albumin and myeloma proteins. J. Clin. Invest. 1958; 3:272-284.

16. Mendelsohn, R.S., Watkin, D.M., Horbett, A.P. and Fahey, J.L. Identification of the vitamin B12-binding protein in the serum of normals and of patients with chronic myelocytic leukemia. Blood. 1958; 1:740-747.

17. Fahey, J.L. and Steinfeld, J.L. Chromatographic differences between radio-iodinated albumin preparations and normal human serum albumin. Proc. Soc. Exp. Bio. and Med. 1958; 9:281-284.

18. Nathans, D., Fahey, J.L. and Potter, M. The formation of myeloma proteins by a mouse plasma cell tumor. J. Exp. Med. 1958; 108:121-130.

19. Fahey, J.L. and Potter, M. Bence Jones proteinuria associated with a transplantable mouse plasma-cell neoplasm. Nature. 1959; 194:654-655.

20. Dutcher, T.F. and Fahey, J.L. The histopathology of the macroglobulinemia of waldenstrom. J. Natl. Cancer Inst. 1959; 22:887-917.

21. Zubrod, C.G., Hilbish, T.F., Fahey, J.L., Dutcher, T.F., Fox, F.A. and Osserman, E.F. Waldenstrom’s macroglobulinemia: Clinical pathological conference. Ann. Int. Med. 1959; 50:1010-1027.

22. Fahey, J.L. and Horbett, A.P. Human gamma globulin fractionation on anion-exchange cellulose solumns. J. Biol. Chem. 1959; 234:2645-2651.

23. Goodman, H.C., Fahey, J.L., Malmgren, R.A. and Brecher, G. Separation of factors in lupus erythematosus serum reacting with components of cell nuclei. Lancet. 1959; 2:382-383.

24. Fahey, J.L. Separation of serum antibody activities by anion-exchange cellulose chromatography. Science. 1960; 1:500-501.

25. Fahey, J.L. and Morrison, E.G. Separation of 6.6S and 18S gamma globulins with isohemagglutinin activity. J. Lab. and Clin. Med. 1960; 55:912-916.

26. Fahey, J.L. and Goodman, H.C. Characterization of antithyroglobulin factors in human serum. J. Clin. Invest. 1960; 39:1259-1265.

27. Goodman, H.C., Fahey, J.L. and Malmgren, R.A. Serum factors in lupus erythematosus and other diseases reacting with cell nuclei and nucleoprotein extracts: Electrophoretic, ultracentrifugal and chromatolographic studies. J. Clin. Invest. 1960; 39:1595-1605.

28. Fahey, J.L., Potter, M., Dutcher, F.J. and Dunn, T.B. Distinctive myeloma globulins associated with a new plasma cell neoplasm of strain C3H mice. Blood. 1960; 15:103-113.

29. Fahey, J.L., Potter, M. and Nathan, D. Myeloma proteins and macroglobulins associated with plasma cell tumors in experimental animals. Acta Union Internationale Contre Cancer. 1960; 16:1136-1140.

30. Potter, M. and Fahey, J.L. Studies on eight transplantable plasma-cell neoplasms of mice. J. Natl. Cancer Inst. 1960; 24:1153-1165.

31. Dunn, T.B., Potter, M., Fahey, J.L. and Merwin, R.M. Morphology and serum protein changes in plasma cell neoplasms in mice. Arch. de Vecchi. 1960; 31:67-77.

32. Dutcher, T.F. and Fahey, J.L. Immunocytochemical demonstration of intranuclear localization of 18S gamma macroglobulin in macroglobulinemia of Waldenstrom. Proc. Soc. Exp. Biol. and Med. 1960; 103:452-455.

33. Fahey, J.L., Dutcher, T.F. and Goodman, H.C. Cell nuclei and gamma macroglobulins. Proc. Roy. Soc. of Med. 1960; 53:627-629.

34. Schwab, P.J. and Fahey, J.L. Treatment of Waldenstrom’s macroglobulinemia by plasmapheresis. NEJM. 1960; 263:574-579.

35. Schwab, P.J., Okum, E. and Fahey, J.L. Reversal of retinopathy in Waldenstron’s macroglobulinemia by plasmapheresis. AMA Arch. Ophthalmology. 1960; 64:515-521.

36. Fahey, J.L. and Boggs, D.R. Serum protein changes in malignant diseases. I. The Acute Leukemias. Blood. 1960; 16:1479-1490.

37. Silver, R.J., Utz, J.P., Fahey, J.L. and Frei, E. Antibody response in patients with acute leukemia. J. Lab. and Clin. Med. 1960; 56:634-643.

38. Shaw, R.K., Boggs, D.R., Szwed, C., Fahey, J.L., Frei, E., Morrison, E. and Utz, J.P. Infection and immunity in chronic lymphocytic leukemia. AMA Arch. Int. Med. 1960; 106:467-478.

39. Boggs, D.R. and Fahey, J.L. Serum protein changes in malignant diseases. II. The chronic leukemias, Hodgkin’s Disease and malignant melanoma. J. Natl. Cancer Inst. 1960; 25:1381-1390.

40. Fahey, J.L. and Askonas, B.A. The significance of myeloma proteins as products of plasma-cell metabolism. Proteins of biological fluid. 8th Colloquium, 1960.

41. Fahey, J.L. Anion-exchange cellulose fractionation of serum proteins, proteins of biological fluid. 8th Colloquium, 1960.

42. Goulian, M. and Fahey, J.L. Abnormalities in serum proteins and protein-bound hexoses in Hodgkin’s disease. J. Lab. and Clin. Med. 1961; 57:408-419.

43. Fahey, J.L. Immunological studies of twenty mouse myeloma proteins: Evidence for two groups of proteins similar to gamma and beta-2A globulins in man. J. Exp. Med. 1961; 144:385-398.

44. Fahey, J.L. Physiocochemical characterization of mouse myeloma proteins: Demonstration of heterogeneity for each myeloma globulin. J. Exp. Med. 1961; 114:399-413.

45. Askonas, B.A. and Fahey, J.L. Formation of Bence Jones protein and myeloma protein in vitro by the plasma cell tumor MPC-2. Biochem. J. 1961; 80:261-268.

46. Askonas, B.A. and Fahey, J.L. An investigation of closely related gamma-myeloma proteins and normal mouse gamma globulin by partial enzymic degradation and starch gel electrophoresis. Nature. 1961; 190:980-983.

47. Humphrey, J.H. and Fahey, J.L. The metabolism of normal plasma proteins and gamma-myeloma protein in mice bearing plasma cell tumors. J. Clin. Invest. 1961; 40:1696-1705.

48. Fahey, J.L. and Lawler, S.D. Gm factors in normal gamma globulin fractions, myeloma proteins and macroglobulins. J. Natl. Cancer Inst. 1961; 27:973.

49. Fahey, J.L. and Humphrey, J.H. Antibodies with differing molecular size in mice. Immunology. 1962; 5:104-109.

50. Fahey, J.L. and Humphrey, J.H. Effect of transplatable plasma cell tumors on antibody response in mice. Immunology. 1962; 5:110-115.

51. Shohl, J., Morrison, E.G., Fahey, J.L. and Schmidt, P.J. The relation of isohemagglutinin levels to gamma-globulin changes in disease. J. Lab. and Clin. Med. 1962; 59:753-759.

52. Fahey, J.L. Chromatographic studies of anomalous gamma, beta2A and macroglobulins and normal gamma-globulins in myeloma and macroglobulinemic sera. J. Biol. Chem. 1962; 237:440-445.

53. Fahey, J.L. and Askonas, B.A. Enzymatically produced subunits of proteins formed by plasma cells in mice. I. Gamma-globulin and gamma-myeloma proteins. J. Exp. Med. 1962; 115:613-639.

54. Askonas, B.A. and Fahey, J.L. Enzymatically produced subunits of proteins formed by plasma cells in mice. II. Beta2A-myeloma protein and Bence Jones protein. J. Exp. Med. 1962; 115:641-653.

55. Fahey, J.L. Evidence for heterogeneity of plasma cells: Studies of proteins produced by plasma cell tumors in inbred mice. Ann. N.Y. Acad. Sci. 1962; 101:212-234.

56. Fahey, J.L. Heterogeneity of gamma-globulins. Advances in Immunology. 1962; 2:41.

57. Cline, M.J., Solomon, A., Berlin, N.I. and Fahey, J.L. Anemia in macroglobulinemia. Am. J. Med. 1963; 34:213-220.

58. Solomon, A., Fahey, J.L. and Malmgren, R.A. Immunohistological localization of gamma-macroglobulins, beta2A -myeloma proteins, 6:6S gamma-myeloma proteins and Bence Jones proteins. Blood. 1963; 21:403-423.

59. Fahey, J.L. Hetrogeneity of myeloma proteins. J. Clin. Invest. 1963; 42:111-123.

60. Fahey, J.L. Studies of gamma- and beta2A-globulins: Comparison of S and F (Papain) fragments of myeloma proteins from inbred mice. J. Immunol. 1963; 90:576-583.

61. Solomon, A. and Fahey, J.L. Plasmapheresis therapy in macroglobulinemia. Ann. Int. Med. 1963; 58:789-800.

62. Fahey, J.L. Serum protein disorders causing clinical symptoms in malignant disease. J. Chronic Diseases. 1963; 16:703-712.

63. Fahey, J.L., Scoggins, R. and Utz, J.P. Infection, antibody response and gamma-globulin components (6.6S, beta2A- and gamma1M globulins) in multiple myeloma and macroglobulinemia. Am. J. Med. 1963; 35:698-707.

64. Solomon, A., Waldmann, T.A. and Fahey, J.L. Metabolism of normal 6.6S gamma-globulin in normal subjects and in patients with macroglobulinemia and multiple myeloma. J. Lab. and Clin. Med. 1963; 62:1-17.

65. Fahey, J.L. Two types of gamma-globulins. In: the Proceedings of the National Research Council Symposium on Gamma-Globulin, pp. 24-31, 1962.

66. Fahey, J.L. and Solomon, A. Two types of gamma-myeloma proteins, beta2A-myeloma proteins, gamma1-macroglobulins and Bence Jones proteins identified by two groups of common antigenic determinants. J. Clin. Invest. 1963; 42:811-822.

67. Fahey, J.L. Two types of 6.6S gamma-globulins, beta2A-globulins and gamma-macroglobulins in normal serum and gamma1 microglobulins in normal urine. J. Immunol. 1963; 91:438-447.

68. Fahey, J.L. Structural basis for the differences between Type I and Type II human gamma-globulin molecules. J. Immunol. 1963; 91:448-459.

69. Fahey, J.L. Two types of gamma-globulins, pp. 50-56. In: Immunopathology, Third International Symposium, Schwabe and Co., Basel, 1963.

70. Fahey, J.L. Evidence for eight normal immunoglobbulins, pp. 27-32. In Proteids of Biological Fluids, 11th Colloquium, H. Peeters (ed.), Elsevier, Amsterdam, 1963.

71. Fahey, J.L. and McLaughlin, C.L. Preparation of antisera for 6.6S gamma-globulins, beta2A-globulins, gamma1-macroglobulins and for Type I and Type II common gamma-globulin determinants. J. Immunol. 1963; 91:484-497.

72. Fahey, J.L. and Lawrence, M.E. Quantitative determination of 6.6S gamma-globulins, beta2A-globulins and gamma1-macroglobulins in human serum. J. Immunol. 1963; 91:597-603.

73. Brecher, G., Tanake, Y., Malmgren, R.A. and Fahey, J.L. Morphology and protein synthesis in multiple myeloma and macroglobulinemia. New York Acad. Sci. 1963; 113:642-653.

74. Terry, W.D. and Fahey, J.L. Immunoelectrophoresis of serum gamma-globulins. In: Proceedings of Applied Seminar on the Serum Proteins and the Dysproteinemias. Assn. of Clinical Scientists, 1963, Philadelphia, PA.

75. Berlin, N.I., Merwin, R., Potter, M., Fahey, J.L., Carbone, P.P. and Cline, M.J. Neoplastic plasma cell. Ann. Int. Med. 1963; 58:1017-1036.

76. Fahey, J.L. The structure of immunoglobulins, pp. 5-8. In: Proceedings of the Applied Seminar on the Serum Proteins and the Dysproteinemias, Assn. of Clinical Scientists, Philadelphia, PA., 1963.

77. Fahey, J.L. Serum proteins in multiple myeloma: Macroglobulinemia and Related Diseases, pp. 182-193. Proceedings of the Applied Seminar on the Serum Proteins and the Dysproteinemias, Assn. of Clinical Scientists, Philadelphia, PA., 1963.

78. Fahey, J.L. and Robinson, A.G. Factors controlling serum gamma-globulin concentration. J. Exp. Med. 1963; 118:845-868.

79. Solomon, A., Waldmann, T., Fahey, J.L. and McFarlane, A.S. Metabolism of Bence Jones protein. J. Clin. Invest. 1964; 43:103-117.

80. Solomon, A. and Fahey, J.L. Bence Jones proteinemia. Am. J. Med. 1964; 37:206-222.

81. Fahey, J.L. and Goodman, H. Antibody activity in six classes of human immunoglobulins. Science. 1964; 143:588-589.

82. Barth, W.F., Wochner, R.D., Waldmann, T.A. and Fahey, J.L. Metabolism of human gamma macroglobulin. J. Clin. Invest. 1964; 43:1036-1048.

83. Sell, S. and Fahey, J.L. Gamma globulin metabolism in germ-gree mice. J. Immunol. 1964; 93:81-87.

84. Mishell, R.E. and Fahey, J.L. Molecular and submolecular localization of two isoantigens (allotypes) in mouse immunoglobulin. Science. 1964; 143:1440-1442.

85. Fahey, J.L. Contribution of gamma-globulin subunits to electrophoretic heterogeneity: Identification of a distinctivr group of 5.5S gamma-myeloma proteins. Immunochemistry. 1964; 1:121-131.

86. Fahey, J.L., Wunderlich, J. and Mishell, R. The immunoglobulins of mice: I. Four major classes of immunoglobulins: 7S gamma2, 7S gamma1, gamma1A (beta 2A) and 18Sgamma 1M-globulins. J. Exp. Med. 1964; 120:223-242.

87. Fahey, J.L., Wunderlich, J. and Mishell, R. The immunoglobulins of mice: II. Two subclasses of mouse 7S gamma2-globulins: gamma2A and gamma2B-globulins. J. Exp. Med. 1964; 120:243-251.

88. Fahey, J.L., Rowe, D.S. and Terry, W.D. Heterogeneity of Human Immunoglobulins, pp. 213-221. In: Proceedings of the Symposium on the Basis of Antibody Formation, Prague, 1964.

89. Terry, W.L. and Fahey, J.L. Subclasses of human gamma2-globulins: (IgG) based on differences in the heavy polypeptide chanis. Science. 1964; 146:400-402.

90. Fahey, J.L. and McKelvey, E.M. Quantitative determination of serum immunoglobulins in antibody-agar plates. J. Immunol. 1965; 94:84-90.

91. Barth, W.F. and Fahey, J.L. Heterologous and homologous skin sensitizing activity of mouse 7S1 and 7S2-globulins. Nature. 1965; 206:730-731.

92. Ovary, Z., Barth, W.F. and Fahey, J.L. The immunoglublins of mice. III. Skin sensitizing activity of mouse immunoglobulins. J. Immunol. 1965; 94:410-415.

93. Fahey, J.L., Barth, W.F. and Ovary Z. Differences in the electrophoretic mobility of antibody from inbred strains of mice. J. Immunol. 1965; 94:819-823.

94. Rowe, D.S. and Fahey, J.L. A new class of human immunoglobulins: I. A unique myeloma protein. J. Exp. Med. 1965; 121:171.

95. Rowe, D.S. and Fahey, J.L. A new class of human immunoglobulins: II. Normal serum IgD. J. Exp. Med. 1965; 121:185-199.

96. Fahey, J.L. Effect of Cancer on the Immune Globulins and Immunity. Proceedings of the 5th National Cancer Conference, pp. 416-420, 1965.

97. Fahey, J.L. and Barth, W.F. The immunoglobulins of mice. IV. Serum immunoglobulin changes following birth. Proc. Soc. Exp. Biol. and Med. 1965; 118:596-600.

98. Barth, W.F., Asofsky, R., Liddy, T.J., Rowe, D.S. and Fahey, J.L. An antibody deficiency syndrome: Selective immunoglobulin deficiency with reduced synthesis of and immunoglobulin polypeptide chains. Amer. J. Med. 1965; 194:225-228.

99. Fahey, J.L., Barth, W.F. and Solomon, A. Serum hyperviscosity syndrome. JAMA. 1965 May 10; 192:464-467.

100. Fahey, J.L. and Terry, E. Ion exchange chromatography and gel filtration, pp. 7.1-7.16. In: Handbook of Experimental Immunology, D.M. Weir (ed.), Blackwell Scientific Pub., 1973.

101. Fahey, J.L. and Sell, S. The immunoglobulins of mice. V. The metabolic (catabolic) properties of five immunoglobulin classes. J. Exp. Med. 1965; 122:41-58.

102. Barth, W.F., McLaughlin, C.L. and Fahey, J.L. The immunoglobulins of mice. VI. Response to immunization. J. Immunol. 1965; 95:781-790.

103. McKelvey, E.M. and Fahey, J.L. Immunoglobulin changes in disease: Quantitation of heavy polypeptide chain classes, IgG, IgA and IgM, and light polypeptide chain types IgK (Type I) and IgL (Type II). J. Clin. Invest. 1965; 44:1778-1787.

104. Fahey, J.L., Barth, W.F. and Law, L.W. Normal immunoglobulins and antibody response in neonatally thymectomized mice. J. Natl. Cancer Inst. 1965; 35:663-678.

105. Fahey, J.L. Antibodies and immunoglobulins. I. Structure and function. JAMA. 1965; 194:71-74.

106. Fahey, J.L. Antibodies and immunoglobulins. II. Normal development and changes in disease. JAMA. 1965; 194:255-258.

107. Ceppeline, R., Dray, S., Fahey, J.L. and 12 additional authors. Notation for genetic factors of human immunoglobulins. Bull. W.H.O. 1965; 33:721-724.

108. Terry, W.D., Fahey, J.L. and Steinberg, A.G. Em and Inv factors in subclasses of human IgG. J. Exp. Med. 1965; 122:1087-1102.

109. Fahey, J.L., Finegold, A\I, Manaker, R.A. and Rabson, A.S. Immunoglobulin synthesis in vitro by established human cell lines. Science. 1966; 152:1259-1261.

110. Pamplet or Bulletin issued by a department of the U.S. Government. Fahey, J.L., Franklin, E., Nezlin, R. and Webb, T. Report of W.H.O. Meeting of Investigators. Information Exchange Group No. 5, Immunopathology, Scientific Memo #173, 1966.

111. Fahey, J.L. and Wirtz, E.W. Ion exchange chromatography and gel filtration, pp. 19-43. In: Handbook of Experimental Pathology, Blackwell Scientific Pub., 1967.

112. Fahey, J.L. Immunoglobulins and myeloma proteins–part of combined staff clinic of the Columbia University College of Physicians and Susrgeons. Am. J. Med. 1968; 44:256-269.

113. Fahey, J.L. Discussion on: Immunologic responsiveness and the induction of experimental neoplasms. Cancer Res. 1966; 26:1133-1134.

114. Rogentine, G.N., Jr., Rowe, D.S., Bradley, J., Waldmann, T.A. and Fahey, J.L. Metabolism of human immunoglobulin D (IgD). J. Clin. Invest. 1966; 45:1467-1478.

115. Ein, D. and Fahey, J.L. Two types of lambda polypeptide chains in human immunoglobulins. Science. 1967; 156:947-948.

116. Kunkel, H.G., Fahey, J.L., Frankllin, E.C., Osserman, E.F. and Terry, W.D. Notation for human immunoglobulin subclasses. Bull. W.H.O. 1966; 35:953.

117. Fahey, J.L. and Finegold, I. Synthesis of immunoglobulins in human lymphoid cell lines. Proc. of the 32nd Cold Spring Harbor Symposium, Vol. 32, 1967.

118. Fahey, J.L., Franklin, E.C., Kunkel, H.G., Osserman, E.F. and Terry, W.D. Notation for human immunoglobulin subclasses. J. Immunol. 1967; 99:465.

119. Finegold, I., Fahey, J.L. and Granger, H. Synthesis of immunoglobulins by human cell lines in tissue culture. J. Immunol. 1967; 99:839-848.

120. Irvin, G.L., III, Eustace, J.C. and Fahey, J.L. Enhancement activity of mouse immunoglobulin classes. J. Immunol. 1967; 99:1085-1091.

121. Fahey, J.L. Prospects for immunotherapy. The Cancer Bulletin. 1968; 20:65-67.

122. Fahey, J.L., Carbone, P.P., Rowe, D.S. and Bachmann, R. Plasma cell myeloma with D-myeloma protein (IgD) myeloma). Amer. J. Med. 1968; 45:373.

123. Finegold, I., Fahey, J.L. and Dutcher, T.F. Immunofluorescent studies of immunoglobulins in human lymphoid cells in continuous culture. J. Immunol. 1968; 101:366.

124. Finegold, I., Hirshaut, Y. and Fahey, J.L. Immunochemical and morphologic comparison of donor tissues with immunoglobulin-producing tissue culture lines from two patients with malignancies. Cancer Research. 1968; 28:1538-1549.

125. Herberman, R.B. and Fahey, J.L. Cytotoxic antibody in Burkitt’s tumor and normal human serum reactive with cultures in lymphoid cells. Proc. Soc. Exp. Biol. Med. 1968; 127:938-940.

126. Mann, D.L., Rogentine, G.N., Jr., Fahey, J.L. and Nathenson, S.G. Solubilization of human leukocyte membrane isoantigens. Nature. 1968; 217:1180.

127. Ein, D., Buell, D.N. and Fahey, J.L. Biosynthetic and structural studies of a heavy chain disease protein. J. Clin. Invest. 1969; 48:785.

128. Fahey, J.L. Chromatographic separation of immunoglobulins. Methods in Immunology and Immunochemistry, Q:321. M. Chase and C. Williams (eds.), Academic Press Inc., New York, N.Y., 1967.

129. Mann, D.L., Rogentine, G.N., Jr., Fahey, J.L. and Nathenson, S.G. Solubilization, properties and molecular separation of HL-A alloantigens. Proc. of the 2nd International Congress of the Tranplantation Society, Transplantation Proc. 1969; 1:494.

130. Mann, D.L., Granger, H. and Fahey, J.L. Use of insoluble antibody for quantitative determination of small amounts of immunoglobulin. J. Immunol. 1969; 102:618.

131. Sanders, J.H., Fahey, J.L., Finegold, I., Ein, D., Reisfeld, R. and Berard, C. Multiple anomalous immunoglobulins: Clinical, structural and cellular studies in three patients. Amer. J. Med. 1969; 47:43.

132. Mann, D.L., Rogentine, G.N., Jr., Fahey, J.L. and Nathenson, S.G. Molecular and heterogeneity of human lymphoid (HL-A) alloantigens. Science. 1969; 163:1460.

133. Buell, D.N. and Fahey, J.L. Limited periods of gene expression in immunoglobulin synthesizing cells. Science. 1969; 164:1524.

134. Fahey, J.L. Developments in fundamental research that relate to clinical uses of immunoglobulins. Conference on Biological Aspects and Clinical Uses of Immunogloublins. Ohio State Univesity, Proc. Natl. Research Council, National Academy of Science, April 1969.

135. Fahey, J.L., Mann, D.L, Asofsky, R., Rogentine, G.N., Jr. Recent Progress in Human Transplantation Immunology. Combined Clinical Staff Conference. Ann. Int. Med. 1969; 71:1177-1196.

136. Mann, D.L., Rogentine, G.N., Fahey, J.L. and Nathenson, S.G. Human lymphocyte membrane (HL-A) alloantigens: Isolation, purification and properties. J. Immunol. 1969; 103:282-292.

137. Rowe, D.S., Anderson, S.G. and Fahey, J.L. A reference preparation for human serum immunoglobulins. J. Immunol. 1969; 102:792-793.

138. Fahey, J.L. Classes of blood-group antibodies. Annals N.Y. Acad. Sci. 1970; 169:164-167.

139. Fahey, J.L. Function of the normal lymphocyte, pp. 187-199. In: Proceedings of Conference on Blood Cells as a Tissue, Holmes, W.L. (ed.), Plenum Press, New York, 1970.

140. Mann, D.L., Fahey, J.L. and Nathenson, S.C. Molecular comparisons of papain solubilized H-2 and HL-A alloantigens, pp. 461-467. In: Histocompatibility Testing, Terasaki, P.I. (ed.), Munksgaard, Copenhagen, 1970.

141. Nathenson, S.G., Shimada, A., Yamane, K., Muramatsu, T., Cullen, S., Mann, D.L., Fahey, J.L. and Graff, R. Biochemical properties of papain-solubilized murine and human histocompatibility alloantigens. Federation Proc. 1970; 29:2026-2033.

142. Buell, D.W., Sox, H.S. and Fahey, J.L. Immunoglobulin production in proliferating lymphoid cells, Chapter 11, pp. 279-296. In: Developmental Aspects of the Cell Cycle, Cameron, I.L., Padilla, G.M., Zimmerman, A.M. (eds.), Academic Press, Inc., New York, 1971.

143. Mann, D.L. and Fahey, J.L. Properties of HL-A alloantigens solubilized by chemical techniques. Transplantation Proc. 1971 Mar; 3(1):234-236.

144. Fahey, J.L. Cancer in the immunosuppressed patient. Annals of Int. Med. 1971; 75:310.

145. Herberman, R.B., Oren, M.E., Rogentine, G.N. and Fahey, J.L. Cytolytic effects of alloantiserum in patients with lymphoproliferative disorders. Cancer. 1971; 28:365.

146. Mann, D.L. and Fahey, J.L. Histocompatibility antigens. Annual Review of Microbiology. 1971; 25:679.

147. Fahey, J.L., Buell, D.N. and Sox, H.C. Proliferation and differentiation of lymphoid cells: Studies with human lymphoid cell lines and immunoglobulin synthesis. Annals N.Y. Acad. Sci. 1971; 190:221.

148. Fahey, J.L. Proliferation and differentiation in human lymphoid and plasma cell lines. Brit. Med. J. 1971; 2:320.

149. Einstein, A.B., Jr., Mann, D.L., Gordon, H.G. and Fahey, J.L. The immune reactivity of heterologous antisera against a solubilized human lymphoid membrane component. Tissue Antigens. 1971; 1(5):209-218.

150. Fahey, J.L. and Hellstrom, I. Tumor antigens: Relationship to histocompatibility antigens. Proc. 1st Intl. Conf. of Immunology, pp. 1343-1345, 1971.

151. Einstein, A.B., Jr., Mann, D.L., Gordon, H.G., Trapani, R-J. and Fahey, J.L. Heterologous antisera against specific HL-A antigens. Transplantation. 1971; 12:299.

152. Rosenberg, E.B., Mann, D.L., Hill, J.J. and Fahey, J.L. Prolonged skin allograft survival in mice pretreated with soluble transplantation antigens. Transplantation. 1971; 12:402.

153. Fahey, J.L. et al. Clinical Immunology. W.H.O. Bulletin #496, Geneva, 1972.

154. Verness, M., Pearson, K.D., Einstein, A.B., Jr. and Fahey, J.L. Osseous manifestations of Waldenstrom’s macroglobulinemia. Diagnostic Radiology. 1972; 102:497.

155. Fahey, J.L. Function of lymphocytes and plasma cells, pp. 791-801. In: Principles of Hematology, W.J. Williams, E. Bentler, C.G. Craddock, A.J. Ersler and R.W. Rundles (eds.), 1972.

156. Amos, B., Bodmer, W.F., Ceppellini, R., Condliffe, P.G., Dausset, J., Fahey J.L., Goodman, H.C., Klein, G. and Klein, J. Biological significance of histocompatibility antigens. Federation Proc. 1972; 31:1087.

157. Fahey, J.L. Cell surfaces and immune activity, pp. 417-428, 1972. In: Multiple Sclerosis: Immunology, Virology and Ultrastructure, Wolfgram, F., Ellison, G.W., Stevens, J.G. and Andrews, J.M. (eds.), Academic Press.

158. Rogentine, G.N., JR., Rosenberg, S.A., Yankee, R.A., Graw, R.G., Jr., Greipp, P., Whang-Peng, J. and Fahey, J.L. Anti-lymphocyte globulin as the sole immunosuppressant for bone marrow transplantation in aplastic anemia. Transplantation. 1973; 15:514-517.

159. Fahey, J.L. Control of proliferation in the immune system, p. 379. In: Proceedings of the Cold Spring Harbor Conferences on Cell Proliferation (eds. Clarkson, Baserga), 1974.

160. Rosenberg, E.B., Hill, J., Ferarri, A., Herberman, R.B., Ting, C-C., Mann, D.L. and Fahey, J.L. Prolonged survival of tumor allografts in mice pretreated with soluble transplantation antigens. J. Natl. Cancer Inst. 1973; 50:1453-1458.

161. Zighelboim, J., Bonavida, B. and Fahey, J.L. Evidence for several cell populations active in antibody dependent cellular cytotoxicity. J. Immunol. 1973; 111:1737.

162. Bloom, E.T., Fahey, J.L., Peterson, I.A., Geering, G., Bernhard, M. and Trempe, G. Anti-tumor activity in human serum: Antibodies detecting blood group-A-like antigen on the surface of tumor cells in culture. Int. J. Cancer. 1973; 12:21.

163. Zighelboim, J., Bonavida, B., Rao, V.S. and Fahey, J.L. Blocking activity induced by solubilized alloantigens. J. Immunol. 1974; 112:433.

164. Zighelboim, J., Bonavida, B. and Fahey, J.L. Heterogenous populations of cytotoxic cells in the peritoneal cavity of BALB/c mice immunized with allogeneic EL-4 leukemia cells. Cellular Immunol. 1974; 12:280.

165. Zighelboim, J., Bonavida, B. and Fahey, J.L. Antibody-mediated in vivo suppression of EL-4 leukemia in a syngeneic host. J. Natl. Cancer Inst. 1974; 52:879.

166. Zighelboim, J., Gale, R.P., Ossorio, R.C. and Fahey, J.L. A sensitive in vitro microassay for detecting antibody-dependent cellular cytotoxicity. Transplantation. 1974; 18:27.

167. Thieme, T.R., Raley, R.A. and Fahey, J.L. Demonstration of molecular individuality of HL-A antigens. J. Immunol. 1974; 113:323.

168. Kedar E., Ortiz de Landazuri, M. and Fahey, J.L. Comparative studies of immunoglobulin receptors and antibody-dependent cell cytotoxicity (ADCC) in rat lymphoid organs. J. Immunol. 1974; 112:37.

169. Kedar, E., Ortiz de Landazuri, M., Bonavida, B. and Fahey, J.L. Cellular immunoadsorbents: II. An improved technique for specific depletion of cytotoxic T-lymphoid cells. J. Immunol. Meth. 1974; 5:97.

170. Ortiz de Landazuri, M., Kedar, E. and Fahey, J.L. Antibody-dependent cellular cytotoxicity (ADCC) to a syngeneic Gross virus-induced lymphoma. J. Natl. Cancer Inst. 1974; 52:147.

171. Ortiz de Landazuri, M., Kedar, E. and Fahey, J.L. Synergistic cooperation between isoantiserum and immune lymphoid cells: in vitro studies with a syngeneic rate lymphoma. J. Immunol. 1974; 112:2102.

172. Ortiz de Landazuri, M., Kedar, E. and Fahey, J.L. Synergism between cytotoxic cells and immune serum in a syngeneic lymphoma: Characterization of two types of cytotoxic cells. International Symposium on Immunological Reactions to Melanoma Antigens, Hanover, 1974 April 16-17.

173. Rao, S., Bonavida, B., Zighelboim, J. and Fahey, J.L. Preferential induction of serum blocking activity and enhancement of skin allografts by soluble alloantigen. Transplantation. 1974; 17:568.

174. Jobin, M.E., Fahey, J.L. and Price, Z. Long-term establishment of a human plasmacyte cell line derived from a patient with IgD multiple myeloma. I. Requirement of a plasmacyte stimulating factor for the proliferation of myeloma cells in tissue culture. J. Exp. Med. 1974; 140:494.

175. Zighelboim, J., Thieme, T., Gale, R.P., Ossorio, R. and Fahey, J.L. A sensitive method for detecting antibodies in human sera used for tissue typing. Transplantation. 1974; 18:180.

176. Zighelboim, J., Gale, R.P., Ossorio, R. and Fahey, J.L. Antibody dependent cellular cytotoxicity: Cytotoxicity-mediated by non-T lymphocytes. Clin. Immunol. and Immunopath. 1974; 3:337-384.

177. Ortiz del Landazuri, M., Kedar, E. and Fahey, J.L. Simultaneous expression of cell-mediated cytotoxicity and antibody-dependent cellular cytotoxicity to a syngeneic rat lymphoma: Separation and partial characterization of two types of cytotoxic cells. Cell.
Immunol. 1974; 14:193-205.

178. Kedar, E., Ortiz de Landasuri, M. and Fahey, J.L. Enzymatic enhancement of cell-mediated cytotoxicity and antibody-dependent cell cytotoxicity. J. Immunol. 1974; 112:26-36.

179. Bloom, E., Ossorio, R.C., Brosman, S. and Fahey, J.L. Cell-mediated cytotoxicity against human bladder cancer. Int. Journal Cancer. 1974; 14:32-334.

180. Gale, R.P., Zighelboim, J., Ossorio, R.C. and Fahey, J.L. A comparison of human lymphoid cells in antibody depedent cellular cytotoxicity (ADCC). Clin. Immunol. and Immunopath. 1975; 3:377-384.

181. Gale, R.P., Opelz, G., Sparkes, R., Zighelboim, J., Fahey, J.L., Cline, M., Craddock, C., Young, L., Feig, S., Smith, G., Terasaki, P.I. and Rupard, N. Bone marrow transplantation between HL-A identical MLC-reactive siblings. Transplantation Proc. 1975; 7 (Supplement):833-839.

182. Cline, M.J., Gale, R.P., Stiehm, E.R., Opelz, G., Young, L.S., Feig, S.A. and Fahey, J.L. Bone marrow transplantation in man. Annals of Int. Med. 1975; 83(5):691-708.

183. Ossorio, R.C., Fahey, J.L., Wilson, E., Brosman, S.A. and Skinner, D. Toxicity of intravenous cornyebacterium parvum. Lancet. 1975; ii:1090-1091.

184. Hausman, M.S., Brosman, S., Synderman, R., Mickey, M.R. and Fahey, J.L. Defective monocyte function in patients with genitourinary carcinoma. Cancer Research. 1975; 35:2693-2698.

185. Durantez, A., Zighelboim, J., Thieme, T. and Fahey, J.L. Antigens shared by leukemic blast cell and lymphoblastoid cell lines detected by lymphocyte-dependent antibody. Cancer Research. 1975; 35:2693-2698.

186. Fahey, J.L. Present status of immunoglobulin research. Arch. Intern. Med. 1975 Jan; 135(1):128-131.

187. Fahey, J.L., Zighelboim, J., O’Toole, C., Ossorio, R.C. and Brosman, S. Immunotherapy and human tumor immunology. Annals of Int. Med. 1976; 84:454-465.

188. Boyer, P. and Fahey, J.L. Stimulation of lymphoid cells from normal and immune mice by syngeneic BALB/c plasma cell tumors. J. Immunol. 1976; 116:202.

189. Elhilali, M., Britton, S., Brosman, S. and Fahey, J.L. Critical evaluation of lymphocyte functions in urologic cancer patients. Cancer Research. 1976; 36:132-137.

190. Boyer, P. and Fahey, J.L. Secondary in vitro lymphocyte proliferative responses to syngeneic plasma cell tumors. Cancer Research. 1976; 36:1492-1498.

191. Gale, R.P., Feig, S., Opelz, G., Territo, M., Young, L., Sarna, G., Fahey, J.L. and Cline, M.J. Bone marrow transplantation in acute leukemia using intensive chemoradiotherapy (SCARI-UCLA). Transplantation Proc. 1976; 8:611-616.

192. Fahey, J.L., Brosman, S. and Dorey, F. Immunological responsiveness in patients with bladder cancer. Cancer Research. 1977; 37:3875-3878.

193. Fahey, J.L. Cancer and the immune response. Chemistry. 1977; 50(5):6-15.

194. Akeson, R., Goldblatt, D., Adey, A., Miyakawa, J., Welch, W., Weimer, H.E. and Fahey, J.L. Isolation and partial characterization of plasma membranes bearing human fetal-associated antigens. Cancer Research. 1977; 37:1468-1475.

195. Brosman, S. and Fahey, J.L. Corynebacterium parvum immunotherapy in bladder cancer patients. In: Neoplasm Immunity: Solid Tumor Therapy, pp. 109-117. R. Crispen (ed), Franklin Institute Press, Chicago, 1977.

196. Elhilali, M., Brosman, S., Vescera, C., Paul, J. and Fahey, J.L. The effects of treatment on delayed cutaneous hypersensitivity responses (DNCB, Croton oil, and recall antigen) in patients with genitourinary. Cancer. 1978; 41(5):1765-1770.

197. Portaro, J.K., Zighelboim, J. and Fahey, J.L. Individual levels of T lymphocytes and Fc receptor cells in the normal population. J. of Clin. and Lab. Immunol. 1978; 1:83-86.

198. Fahey, J.L. Principles of immunology with relevance to immunotherapy. Raven Press, N.Y., Immunotherapy of Human Cancer, pp. 31-39, 1978.

199. Zighelboim, J., Parker, N.H., Ossorio, C., Calcaterra, T., Ward, P., Fahey, J.L. and Fischer, S. Phase I studies of C parvum given intravenously. Cancer. 1978; 51:1298-1306.

200. Zighelboim, J., Schott, J. and Fahey, J.L. The stimulation of DNA synthesis by leukemia myeloblasts in inhibited by antisera to human B cell associated antigens. Leukemia Research. 1978; 2(3):223-230.

201. Portaro, J.K., Zighelboim, J. and Fahey, J.L. Hereditary Deficiency of K cells in a normal subject. Clin. Immunol. and Immunopath. 1978;11:458-469.

202. Nathanson, S.D., Zamfirescu, P.L., Portaro, J.K., deKernion, J.B. and Fahey, J.L. Acute effects of orally administered levamisole on random monocyte motility and chemotaxis in man. J. Natl Cancer Inst. 1978; 61(2):301-306.

203. Zighelboim, J., Dorey, F., Parker, N., Calcaterra, T., Ward, P. and Fahey, J.L. Immunologic evaluation of patients with advanced head and neck cancer receiving weekly chemoimmunotherapy. Cancer. 1979; 44:117-123.

204. Brosman, S., Elhilali, M., Vescera, C. and Fahey, J.L. Immune response in bladder cancer patients. J. Urology. 1979; 121:162-169.

205. Fahey, J.L. HLA and immune response. In: Pediatric Immunology, pp. 33-40. H. Hoder and B.M. Kagan (eds.), Science and Medicine Publishing Co., 1979.

206. Fahey, J.L. and Zighelboim, J. Tumor Immunology. In: Clinical Immunology, pp. 445-472. C. Parker (ed), W.B. Saunders and Co., 1980.

207. Lichtenstein, A., Zighelboim, J., Dorey, F., Brosman, S. and Fahey, J.L. Comparison of immune derangements in patients with different malignancies. Cancer. 1980; 45:2090-2095.

208. Hofman, F., Spina, C.A., Rand, N. and Fahey, J.L. Soluble suppressor factor produced by pokeweed mitogen-stimulated human peripheral blood leukocytes. Cellular Immunol. 1980; 55:20-31.

209. Spina, C.A., Smith, D., Korn, E., Fahey, J.L. and Grossman, H.J. Altered cellular immune functions in patients with Down’s syndrome. Am. J. Dis. Child. 1981; 135:251-255.

210. Spina, C.A., Dorey, F., Vescera, C., Brosman, S. and Fahey, J.L. Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patients. Cancer Research. 1981; 41:4324-4330.

211. Hofman, F., Rand, N. and Fahey, J.L. Adherent cell requirement for PWM-stimulated factor suppression of natural killer cytotoxicity. J. Cellular Immunol. 1981; 58:356-365.

212. Walford, R.L., Barnett, E.V., Chia, D., Fahey, J.L., Gatti, R.A., Gossett, T.C., Grossman, H., Hibrawi, H., Medici, M.A., Motala, M., Naeim, F., Sparkes, R.S., Spina, C., Tam, C.F., and Van Lancker, J.L. In: Immunological Aspects of Aging, Segre and Smith (eds). Marcel Dekker, Inc., pp. 479-532, 1981.

213. Gale, R.P., Ho, W., Feig, S., Champlin, R., Tesler, A., Arenson, E., Ladish, S. Young, L., Winston, D., Sparkes, R., Fitchen, J., Territo, M., Sarna, G., Wong, L., Paik, Y., Bryson, Y., Golde, D., Fahey, J.L. and Cline, M. Prevention of graft rejection following bone marrow transplantation. Blood. 1981; 57:9-12.

214. Spina, C., Dorey, F., Vescera, C., Brosman, S. and Fahey, J.L. Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patients. Cancer Research. 1981; 41:4324-4330.

215. Schroff, R.W., Foon, K.A., Billings, R.J. and Fahey, J.L. Immunologic classification of lymphocytic leukemias based on monoclonal antibody-defined cell surface antigens. Blood. 1982; 59:207-215.

216. Schroff, R.W., Gale, R.P. and Fahey, J.L. Regeneration of T cell subpopulations following marrow transplantation: Cytomegalovirus infection and lymphoid subset imbalance. J. Immunol. 1982; 129:1926-1930.

217. Schroff, R.W., Gale, R.P. and Fahey, J.L. Lymphoid immaturity and T-subpopulation imbalances in human disease. B and T Cells, pp. 285-291, Academic Press, Inc., 1982.

218. Messing, E.M., Fahey, J.L., de Kernion J.B., Bhuta, S.M. and Bubbers, J.E. Serum-free medium for the in vitro growth of normal and malignant urinary bladder epithelial cells. Cancer Research. 1982; 42:2392-2397.

219. Shih, W.W.H., Ellison, G.W., Myers, L.W., Durkos-Smith, D. and Fahey, J.L. Locus of selective suppression of human natural killer (NK) cells by azathioprine. Clin. Immunol. and Immunopath. 1982; 23:672-681.

220. Uittenbogaart, C. and Fahey, J.L. Leukemia derived growth factor (non-interleukin-2) produced by a human malignant T lymphoid cell line. Proc. Natl. Acad. Sci. 1982; 79:7004-7008.

221. Uittenbogaart, C.H., Cantor, Y., Fahey, J.L. Growth of human malignant lymphoid cell lines in serum-free medium. In Vitro. 1983; 19(1):67-72.

222. Spina, C.A., Fahey, J.L., Durkos-Smith, D., Dorey, F. and Sarna, G. Suppression of natural killer cell cytotoxicity in the peripheral blood of patients receiving interferon therapy. J. Biol. Resp. Modifiers. 1983; 2:458-469.

223. Shih, W.W.H., Baumhefner, R.W., Tourtellotte, W.W., Haskell, C.M., Korn, E.L. and Fahey, J.L. Differences in effect of single immunosuppressive agnets (cyclohexamide, CCNU, 5FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis. Clinical Exp. Immunol. 1983; 53:122-130.

224. 224. Schroff, R.W., Gottlieb, M.S., Prince, H.E., Chai, L.L. and Fahey, J.L. Immunological studies of homosexual men with immunodeficiency and Kaposi’s Sarcoma. Clin. Immunol. and Immunopath. 1983; 27:300-314.

225. Prince, H.W., Gottlieb, M.S. and Fahey, J.L. Acquired immune deficiency syndromes: A review of immunological aspects. Clinical Immunology Newsletter. 1983; 4:44-47.

226. Detels, R., Fahey, J.L., Schwartz, K., Greene, R.S., Visscher, B.R. and Gottlieb, M.S. Relation between sexual practices and T cell subsets in homosexually active men. Lancet. 1983; 8325(1):609-611.

227. Fahey, J.L., Detels, R. and Gottlieb, M.S. Immune cell augmentation (with altered T subset ratio) is common in healthy homosexual men. NEJM. 1983; 308:842-843.

228. Gottlieb, M.S., Groopman, J.E., Weinstein, W., Fahey, J.L. and Detels, R. The acquired immunodeficiency syndrome. Annals of Int. Med. 1983; 99(2):208-220.

229. Uittenbogaart, C.H. and Fahey, J.L. Non-interleukin-2 T cell growth factor. In: Intercellular Communication in Leucocyte Function (Proceedings of the 15th Leucocyte Culture Conference), pp. 41-45, 1983.

230. Fahey, J.L., Prince, H., Weaver, M.M, Groopman, J., Visscher, B., Schwartz, K. and Detels, R. Quantitative changes in Th or Ts lymphocyte subsets that distinguish AIDS syndrome from other immune subset disorders. Am. J. Med. 1984; 76:95-100.

231. Kreiss, J.K., Kasper, C.K., Fahey, J.L., Weaver, M., Lawrence, D.N., Stewart, J.A. and Visscher, B.R. Nontransmission of T cell subset abnormalities from hemophiliacs to their spouses. JAMA. 1984; 251(11):1450-1454.

232. Detels, R., Visscher, B.R., Fahey, J.L., Schwartz, K., Greene, R.S., Madden, D.L. Sever, J.L. and Gottlieb, M.S. The relation of cytomegalovirus and Epstein-Barr virus antibodies to T cell subsets in homosexually active men. JAMA. 1984; 251(13):1719-1722.

233. Groopman, J., Gottlieb, M.S., Goodman, J., Mitsuyasu, R., Conant, M., Prince, H.W., Fahey, J.L., Derezin, M., Rothman, J., Weinstein, W., Rudnick, S. and Volberding, P. Recombinant alpha interferon therapy of Kaposi’s Sarcoma associated with acquired immunodeficiency syndrome. Annals of Int. Med. 1984; 100:671-676.

234. Prince, H.W., Kermani-Arab, V. and Fahey, J.L. Depressed interleukin-2 receptor expression in acquired immune deficiency and lymphadenopathy syndromes. J. Immunol. 1984; 133:1313-1317.

235. Prince, H.W., Schroff, R.W., Ayoub, G., Han, S., Gottlieb, M.S. and Fahey, J.L. HLA studies in homosexual men with Kaposi’s Sarcoma and immunodeficiency. J. Clin. Immunol. 1984; 4(3):242-245.

236. Prince, H.W., Ettenger, R.B., Dorey, F.J., Fine, R.N. and Fahey, J.L. Azathioprine suppression of natural killer activity and antibody-dependent cellular cytotoxicity in renal transplant recipients. J. Clin. Immunol. 1984; 4(4):312-318.

237. Kermani-Arab, V., Hirji, K., Ahmed, A.R., and Fahey, J.L. Deficiency of interleukin-2 production and interleukin-2 receptor stimulation in pemphigus. J. Invest. Dermatol. 1984; 83:101-104.

238. Messing, E.M., Bubbers, J.E., Whitmore, K.E., deKernion, J.B., Nestor, M.S., and Fahey, J.L. Murine hybridoma antibodies against human transitional carcinoma-associated antigens. J. Urology. 1984; 132:167-172.

239. Messing, E.M., Bubbers, J.E., deKernion, J.B., and Fahey, J.L. Growth stimulating activity produced by bladder cancer cells. J. Urology. 1984; 132:1230-1234.

240. Ellison, G.W., Visscher, B.R., Graves, M.C., and Fahey, J.L. Multiple sclerosis. Ann. Int. Med. 1984; 1001:514-526.

241. Seligmann, M., Chess, L., Fahey, J.L., Fauci, A.S., Lachmann, P., L’Age-Stehr, J., Pinching, A.J., Rosen, F.S., Spira, T.J., and Wybran, J. AIDS: An immunologic reevaluation. NEJM. 1984; 311:1286-1292.

242. 242. Korn, E., Dorey, F., Spina, C., and Fahey, J.L. The use of three baseline values in intervention studies. Application to evaluation of immune modulation therapies. Immunobiology. 1984; 167:431-436.

243. Ellison, G.W., Myers, L.W., Mickey, M.R., France, M.V., Tourtellotte, W.W., Spina, C.S., and Fahey, J.L. Therapeutic trials in multiple sclerosis: Azathioprine. Ann. N.Y. Acad. Sci. 1984; 436:361-365.

244. Salazar-Gonzalez, J.F., Moody, D.J., Giorgi, J.V., Martinez-Maza, O., Mitsuyasu, R.T., and Fahey, J.L. Reduced ecto-5′-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: Evidence of CD8 cell immaturity. J. Immunol. 1985; 135:1778-1785.

245. Prince, H., Moody, D., Shubin, B., and Fahey, J.L. Defective monocyte function in AIDS: Evidence from monocyte-dependent T cell proliferative system. J. Clin. Immunol. 1985; 5:21-25.

246. Chopin, D.K., deKernion, J.B., Rosenthal, D.L., and Fahey, J.L. Monoclonal antibodies against transitional cell carcinoma for detection of malignant urothelial cells in bladder washing. J. Urology. 1985; 134:260-265.

247. Fahey, J.L., Plaeger-Marshall, S. and Moody, D.J. Assessment of cellular immune parameters in disease. Clin. Immunol. Today. 1985; 13:3-8.

248. Fahey, J.L., Taylor, J., Afrasiabi, R., Weaver, M. and Mitsuyasu, R. AIDS and Kaposi’s Sarcoma. In: Immunity to Cancer, pp. 347-361. A.E. Reif and M.S. Mitchell (eds), Academic Press, Inc., N.Y., 1985.

249. Giorgi, J.V. and Fahey, J.L. Acquired immune deficiency syndrome: Effects of HTLV-III on T cell populations. Laboratory Management. 1985; 23:31-35.

250. Gottlieb, M.S., Wolfe, P.R., Fahey, J.L., Knight, S., Hardy, D., Eppolito, L., Ashida, E., Patel, A., Beall, G.N. and Sun, N. The syndrome of pertistent generalized lymphadenopathy: Experience with 101 patients. In: AIDS Associated Syndromes, pp. 85-91, Plenum Publishing Company, New York, 1985.

251. Schwartz, K., Visscher, B.R., Detels, R., Taylor, J., Nishanian, P. and Fahey, J.L. Immunological changes in lymphadenopathy virus positive and negative symptomless male homosexuals: Two years of observation. Lancet. 1985; 2:831-832.

252. Taylor, J., Afrasiabi, R., Fahey, J.L., Korns, E., Weaver, M. and Mitsuyasu, R. A prognostically significant classification of immune changes in AIDS with Kaposi’s Sarcoma. Blood. 1986; 67(3):666-671.

253. Fahey, J.L., Taylor, J.M.G., Korns, E., and Nishanian, P. Diagnostic and prognostic factors in AIDS. The Mt. Sinai J. Med. 1986; 53(8):657-663.

254. Mitsuyasu, R.T., Taylor, J., and Fahey, J.L. Heterogeneity of epidemic Kaposi’s Sarcoma: Implications for therapy. Cancer. 1986; 57:1657-1661.

255. Taylor, J.M.G., Plaeger-Marshall, S., and Fahey, J.L. A statistical method for assessing change in immunologic parameters in a patient. J. Clin. Immunol. 1986; 6(3):249-255.

256. Moody, D.J., Fahey, J.L., Durkos-Smith, D., Ellison, G.W. and Myers, L.W. Cytosine arabinoside induced changes in natural killer and antibody dependent cellular cytotoxicity functions in multiple sclerosis patients. Immunopharmac. 1986; 8(2):259-269.

257. Afrasiabi, R., Mitsuyasu, R., Nishanian, P., Schwartz, K., and Fahey, J.L. Characterization of a distinct subgroup of high-risk persons with Kaposi’s Sarcoma and good prognosis who present with normal T4 cell number and T4:T8 ratio and negative HTLV-III/LAV serologic test results. Amer. J. Med. 1986; 81:969-973.

258. Neuwirth, H., Zhu, L.W., Stock, L.M., Liu, B.C.S., and Fahey, J.L. Glycoprotein as a tumor marker in urine of patients with bladder cancer. Surgical Forum. 1986; 37:657-658.

259. Uittenbogaart, C.J., Nishanian, P.G., Anisman, D.J., Erickson, T.K. and Fahey, J.L. Leukemia derived growth factors produced by human malignant T-lymphoid cell lines. Cancer Res. 1986; 46(3):1219-1223.

260. Fahey, J.L. Immunologic aspects of human immunodeficiency virus infection and AIDS. In: Clinical Aspects of Autoimmunity, 1(2), pp. 12-23, TransMedica, N.Y., 1986.

261. Moody, D.J., Fahey, J.L., Grable, E., Ellison, G.W. and Myers, L.W. Administration of monthly pulses of cyclophosphamide in multiple sclerosis patients: Delayed recovery of several immune parameters following discontinuation of long-term cyclophosphamide treatment. J. Neuroimmunol. 1987; 14:175-182.

262. Mickey, M.R., Ellison, G.W., Fahey, J.L., Moody, D.J. and Myers, L.W. Correlation of clinical and immunologic states in multiple sclerosis. Arch. Neurol. 1987; 44:371-375.

263. Martinez-Maza, O., Moody, D.J., Rezai, A.R., Ellison, G.W., Myers, L.W., Tourtellotte, W.W. and Fahey, J.L. Increased spontaneous immunoglobulin secretion associated with cyclophosphamide-induced immune suppression. J. Clin. Immunol. 1987; 7:107-113.

264. Ojo-Amaize, E., Nishanian, P., Keith, D.E., Houghton, R.L., Heitjan, D.F., Fahey, J.L. and Giorgi, J.V. Antibodies to HIV in human sera induced cell-mediated lysis of HIV-infected cells. J. Immunol. 1987; 139(7):2458-2463.

265. Nishanian, P.N., Taylor, J.M.G., Korns, E., Detels, R. Saah, A. and Fahey, J.L. Significance of quantitative enzyme-linked immunosorbent assay (ELISA) results in evaluation of 3 ELISAs and Western Blot tests for detection of antibodies to human immunodeficiency virus in a high-risk population. J. Clin. Microbiol. 1987; 25(2):395-400.

266. Detels, R., Visscher, B.R., Fahey, J.L., Sever, J.L. Gravell, M., Madden, D.L., Schwartz, K., Dudley, J., English, P.A., Powers, H., Clark, V.A. and Gottlieb, M.S. Predictors of clinical AIDS in young homosexual men in a high-risk area. Intl. J. Epi. 1987; 16(2):271-276.

267. Saah, A.J., Farzadegan, H., Fox, R., Nishanian, P., Rinaldo, C.R., Phair, J., Fahey, J.L., Lee, T.-H. and Polk, B.F. Detection of early antibodies in human immunodeficiency virus infection by enzyme-linked immunosorbent assay, western blot and radioimmunoprecipitation. Clin. Microbiol. 1987; 15(9):1605-1610.

268. Fahey, J.L., Giorgi, J.V., Martinez-Maza, O., Detels, R. and Taylor, J.M.G. Immune pathogenesis of AIDS and related syndromes. Ann. Inst. Pasteur/Immunol. 1987; 138:245-252.

269. Seligmann, M., Pinching, A.J., Rosen, F.S. Fahey, J.L., Khaitov, R.M., Klatzmann, D., Koenig, S.,Luo, N., Ngu, J., Riethmuller, G., and Spira, T.J. Immunology of HIV infection and AIDS: An update. Ann. Int. Med. 1987; 107:234-242.

270. Stock, L.M., Brosman, S.A., Fahey, J.L. and Liu, B.C.S. Ras related oncogene protein as a tumor marker in transitional cell carcinoma of the bladder. J. Urology. 1987; 137:789-792.

271. Liu, B.C.S., Neuwirth, H., Zhu, L.W., Stock, L.M., deKernion, J.B. and Fahey, J.L. Detection of onco-fetal bladder antigen in urine of patients with transitional cell carcinoma. J. Urology. 1987; 137:1258-1261.

272. Martinez-Maza, O., Crabb, E., Mitsuyasu, R.T., Fahey, J.L. and Giorgi, J.V. Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J. Immunol. 1987; 138(1):3720-3724.

273. Fahey, J.L. and Ojo-Amaize, E. Acquired immune deficiency syndrome (AIDS) and neoplasia. Amer. J. Ped. Hematol./Oncol. 1987; 9(2):193-195.

274. Fahey, J.L., Sarna, G., Gale, R.P. and Seeger, R. Immune interventions in disease. Ann. Int. Med. 1987; 106(2):257-274.

275. Gottlieb, M.S., Detels, R. and Fahey, J.L. T cell phenotyping in the diagnosis and anagement of AIDS and AIDS-related diseases. In: Current Topics in AIDS (M.S. Gottlieb, ed.), pp. 211-223, John Wiley and Sons, 1987.

276. Giorgi, J.V., Fahey, J.L., Smith, D.C., Hultin, L., Cheng, H.-L., Mitsuyasu, R.T. and Detels, R. Early effects of HIV on CD4 lymphocytes in vivo. J. Immunol. 1987; 138(11):3725-3730.

277. Nishanian, P., Taylor, J., Fahey, J.L., Detels, R. and Saah, A. Comparison of several ELISA and Western blot tests for antibodies to HIV in a high risk population. In: Clinical Immunology, pp. 231-234. W. Pruzanski and M. Seligmann (eds), Elsevier Science Publishers, 1987.

278. Sano, K., Lee, M.H., Morales, F., Nishanian, P., Fahey, J.L., Detels, R. and Imagawa, .T. Antibody that inhibits human immunodeficiency virus reverse transcriptase and association with inability to isolate virus. J. Clin. Microbiol. 1987; 25(12):2415-2417.

279. Kedar, E., Rezai, A.R., Giorgi, J.V., Gale, R., Champlin, R.E., Mitsuyasu, R.T. and Fahey, J.L. Immunomodulating effects in vitro of interleukin-2 (IL-2) and interferon-gamma (IFN-g) on human blood and bone marrow mononuclear cells. Nat. Immun. and Cell Growth Regul. 1988; 7:13-30.

280. Munoz, A., Carey, V., Saah, A.J., Phair, J.P., Kingsley, L.A., Fahey, J.L., Ginzburg, H.M. and Polk, B.F. Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with Human Immunodeficiency Virus. J. Acq. Immun. Def. Synd. 1988; 1:396-404.

281. Detels, R., English, P.A., Giorgi, J.V., Visscher, B.R. Fahey, J.L., Taylor, J.M.G., Dudley, J.P., Nishanian, P., Munoz, A., Phair, J.P., Polk, B.F. and Rinaldo, C.R. Patterns of CD4+ cell changes after HIV-1 infection indicate the existence of a codeterminant of AIDS. J. Acq. Immun. Def. Synd. 1988; 1(4):390-395.

282. Fahey, J.L. and Liu, B.C.S. Cancer and the immune response. Cancer: The Outlaw Cell, 2nd edition, Chapter 9, pp. 143-158 (R.E. LaFond, ed.), Amer. Chem. Soc., Washington, D.C., 1988.

283. Martinez-Maza, O., Figlin, R.A., Giorgi, J.V. and Fahey, J.L. Selective decrease in Leu8-negative T cell subpopulations following treatment with recombinant interferon-alpha2a (rIFN-alpha2a). Cellular Immunol. 1988; 117:89-98.

284. Fahey, J.L. and Hofmann, B. Introduction and overview on AIDS. In: Advances in Immunopharmac. 4 (J.W. Hadden, ed.), Pergamon Press, Oxford, pp. 3-10, 1988.

285. Ojo-Amaize, E., Nishanian, P.G., Heitjan, D.F., Rezai, A., Esmail, I., Korns, E., Detels, R., Fahey, J.L. and Giorgi J.V. Serum and effector-cell ADCC activity remains high during HIV disease progression. J. Clin. Immunol. 1989; 9(6):454-461.

286. Melmed, R.N., Taylor, J.M.G., Detels, R., Bozorgmehri, M. and Fahey, J.L. Serum neopterin changes in HIV-infected subjects: Indicator of significant pathology, CD4 T cell changes and the development of AIDS. J. Acq. Immun. Def. Synd. 1989; 2(1):70-76.

287. Martinez-Maza, O., Mitsuyasu, R.T., Miles, S.A., Giorgi, J.V., Heitjan, D.F., Sherwin, S.A. and Fahey, J.L. Gamma interferon induced monocyte major histocompatibility complex class II antigen expression in individuals with Acquired Immune Deficiency Syndrome. Cellular Immunol. 1989; 123:316-324.

288. Taylor, J.M.G., Fahey, J.L., Detels, R. and Giorgi, J.V. CD4 percentage, CD4 number and CD4:CD8 ratio in HIV infection: Which to choose and how to use. J. Acq. Immun. Def. Synd. 1989; 2:114-124.

289. Fahey, J.L., Melmed, R.N., Detels, R., Taylor, J.M.G., and Hofmann, B. Neopterin changes in early and late HIV infection. Biochemical and Clinical Aspects of Pterdines, 1989; 370:379.

290. Nakajima, K., Martinez-Maza, O., Hirano, T., Breen, E.C., Nishanian, P.G., Salazar-Gonzalez, J., Fahey, J.L. and Kishimoto, T. Induction of IL-6 (B cell stimulatory factor-2/IFN-beta2) production by HIV. J. Immunol. 1989; 142(2):531-536.

291. Nakajima, K., Martinez-Maza, O., Hirano, T., Breen, E.C., Nishanian, P.G., Salazar-Gonzalez, J.F., Fahey, J.L. and Kishimoto, T. HIV-induced B cell stimulatory factor 2/interleukin-6 (BSF2/IL-6) production. Annals of the New York Academy of Sciences. 1989; 557:521-524.

292. Fahey, J.L. Foreword. Evaluation of the immune system during HIV infection and AIDS: T cell subsets. Clinical Immunol. and Immunopathol. 1989; 52:1-2.

293. Imagawa, D.T., Lee, M.H., Wolinsky, S.M., Sano, K., Morales, F., Kwok, S., Sninsky, J.J., Nishanian, P.G., Giorgi, J.V., Fahey, J.L., Dudley, J., Visscher, B.R. and Detels, R. Human immunodeficiency virus type 1 in homosexual men who remain seronegative for prolonged periods. NEJM. 1989; 320:1458-1462.

294. Fahey, J.L., Taylor, J.M.G., Detels, R., Hofmann, B., Melmed, R.N., Nishanian, P. and Giorgi, J.V. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. NEJM. 1990; 322:166-172.

295. Fawzy, F.I., Cousins, N., Kemeny, M.E., Fawzy, N., Elashoff, R., Morton, D. and Fahey, J.L. A structured psychiatric intervention for cancer patients: II. Changes over time in immunological measures. Archives of General Psychiatry. 1990; 47:729-735.

296. Shau, H., Ibayashi, Y., Isacescu, V., Tokuda, Y., Golub, S.H., Fahey, J.L. and Sarna, G.P. A pilot study of intralymphatic IL-2 cytotoxic and surface marker changes of peripheral blood lymphocytes. Journal of Biologic Response Modifiers. 1990; 9:71-80.

297. Faisal, M., Cumberland, W., Champlin, R. and Fahey, J.L. Effect of recombinant human GM-CSF administration on the lymphocyte subsets of patients with refractory aplastic anemia. Blood. 1990; 76(8):1580-1585.

298. Nishanian, P., Huskins, K.R., Stehn, S., Detels, R. and Fahey, J.L. A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals. J. Inf. Dis. 1990; 162:21-28.

299. Hofmann, B., Nishanian, P., Baldwin, R.L., Insixiengmay, P., Nel A. and Fahey, J.L. HIV inhibits the early steps of lymphocyte activation, including initiation of inositol phospholipid metabolism. J. Immunol. 1990; 145(11):3699-3705.

300. Fahey, J.L. Doing it right: Measuring T cell subsets by flow cytometry. Editorial. Clin. Immunol. and Immunopath. 1990; 55:171-172.

301. Hofmann, B., Wang, Y., Cumberland, W.G., Detels, R., Bozorghmehri, M. and Fahey, J.L. Serum b2-microglobulin (b2M) level increases in HIV infection: Relation to seroconversion, CD4 T cell fall and prognosis. AIDS. 1990; 4:207-214.

302. Chiappelli, F., Myers, L.W., Ellison, G.W., Liao, D. and Fahey, J.L. Preferential reductions in lymphocyte sub-populations induced by monthly pulses of chlorambucil: Studies in patients with chronic progressive multiple sclerosis. Int. J. Immunopharmac. 1991; 13:455-461.

303. Chiappelli, F., Yamashita, N., Faisal, M., Kemeny, M., Bullington, R., Nguyen L., Clement, L.T. and Fahey, J.L. Differential effect of beta-endorphin on three human cytotoxic cell populations. Int. J. of Immunopharmac. 1991; 13(2/3):291-297.

304. Chiappelli, F., Gwirtsman, H.E., Lowy, M., Gormley, G., Nguyen, L.D., Nguyen L., Popow, J., Esmail, I., Fahey, J.L. and Strober, M. Pituitary-adrenal-immune system in normal subjects and in patients with anorexia nervosa: The number of circulating helper T lymphocytes (CD4) expressing the homing receptor Leu 8 is regulated in part by pituitary-adrenal products. Psychoneuroendocrinology. 1991; 16(5):423-432.

305. Naliboff, B.D., Benton, D., Solomon, G.F., Morley, J.E., Fahey, J.L., Bloom, E.T., Makinodan, T. and Gilmore, S.L. Immunological changes in young and old adults during brief laboratory stress. Psychosomatic Medicine. 1991; 53(2):121-132.

306. Nishanian, P., Hofmann, B., Wang, Y., Jackson, A.L., Detels, R. and Fahey, J.L. Serum soluble CD8 molecule is a marker of CD8 T cell activation in HIV-1 disease. J. Acq. Immun. Def. Synd. 1991; 5:805-812.

307. Hofmann, B., Nishanian, P., Fahey, J.L., Esmail, I., Jackson, A.L., Detels, R. and Cumberland, W. Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: Distinctive parameters of HIV-induced change. Clin. Immunol. and Immunopath. 1991; 61:212-224.

308. Hofmann, B., Bass, H., Nishanian, P., Faisal, M., Figlin, R.A., Sarna, G.P. and Fahey, J.L. Different lymphoid cell populations produce varied levels of neopterin, beta-2 microglobulin and sIL-2R when stimulated by IL-2, INF-gamma or TNF-alpha. Clin. Exp. Immunol. 1992; 88:548-554.

309. Fahey, J.L., Hofmann, B., Nishanian, P. and Bass H. Immune abnormalities and control of AIDS. Progress in Allergy and Clinical Immunology. 1992; 2:276-281.

310. Bass, H.Z., Hardy, W.D., Mitsuyasu, R.T., Taylor, J.M.G., Wang, Y.X., Fischl, M., Spector, S.A., Richman, D.D. and Fahey, J.L. The effect of zidovudine treatment on serum neopterin and beta-2 microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals. J. Acq. Immun. Def. Synd. 1992; 5:215-221.

311. Bass, H.Z., Nishanian, P., Hardy, W.D., Mitsuyasu, R.T., Esmail, I., Cumberland, W. and Fahey, J.L. Immune changes in HIV-1 infection: Significant correlations and differences in serum markers and lymphoid phenotypic antigens. Clin. Immunol. and Immunopath.1992; 64(1):63-70.

312. Bass, H.Z., Hardy, W.D., Mitsuyasu, R.T., Wang, Y.X., Cumberland, W. and Fahey, J.L. Eleven lymphoid phenotypic markers in HIV infection: Selective changes induced by zidovudine treatment. J. Acq. Immun. Def. Synd. 1992; 5(9):890-897.

313. Fahey, J.L. and Schooley, R. Status of immune-based therapies in HIV infection and AIDS. Clin. Exp. Immunol. 1992; 88:1-5.

314. Popow, J., McGraw, T., Hofmann , B., Vowels, B., Shum, A., Nishanian, P. and Fahey, J.L. Acute lymphoid changes and ongoing immune activation in SIV infection. J. Acq. Immun. Def. Synd. 1992; 5:391-399.

315. Chiappelli, F., Nguyen, L., Bullington, R. and Fahey, J.L. Beta-endorphin blunts phosphatidylinositol formation during in vitro activation of isolated human lymphocytes: Preliminary report. Brain, Behavior and Immunity. 1992; 6:1-10.

316. Futterman, A.D., Kemeny, M.E., Shapiro, D., Polonsky, W. and Fahey, J.L. Immunological variability associated with experimentally-induced positive and negative affective states. Psychological Medicine. 1992; 22:231-238.

317. Hofmann, B., Nishanian, P., Nguyen, T., Insixiengmay, P. and Fahey, J.L. HIV proteins induce the inhibitory cAMP/Protein kinase pathway in normal lymphocytes. PNAS 1993; 90:6676-6680.

318. Hofmann, B., Nishanian, P., Nguyen, T., Liu, M., Martinez-Maza, O. and Fahey, J.L. Restoration of T cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS. 1993; 7:659-664.

319. Yamashita, N., Nguyen, L., Fahey, J.L. and Clement, L.T. Phenotypic properties and cytotoxic functions of human CD8+ cells expressing the CD57 antigen. Nat. Immun. 1993; 12:79-91.

320. Graham, M.H., Piantadosi, S., Park, L.P., Phair, J.P., Rinaldo, C.R. and Fahey, J.L. CD4+ lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time. J. Acq. Immun. Def. Synd. 1993; 6:1258-1266.

321. Fan, J., Bass, H.Z. and Fahey, J.L. Elevated IFN and decreased IL-2 gene expression are associated with HIV infection1. J. Immunol. 1993; 151(9):5031-5040.

322. Fahey, J.L. Update on AIDS. The Immunologist. 1993; 1/4:131-132.

323. Fawzy, F., Fawzy, N.W., Hyun, C.S., Elashoff, R., Guthrie, D., Fahey, J.L. and Morton, D. Malignant Melanoma: Effects of an early structured psychiatric intervention, coping, an affective state on recurrence and survival six years later. Archives of General Psychiatry. 1993; 50:681-689.

324. Kemeny, M., Weiner, H., Taylor, S.E., Schneider, S., Visscher, B. and Fahey, J.L. Repeated bereavement, depressed mood and immune parameters in HIV seropositive and seronegative homosexual men. Health Psychology. 1994; 13(1):14-24.

325. Futterman, A.D., Kemeny, M.E., Shapiro, D. and Fahey, J.L. Immunological and physiological changes associated with induced positive and negative mood. Psychosomatic Medicine. 1994; 56:499-511.

326. Sarna, G., Machleder, J., Collins, J., Bonavida, B., Jacobs, E., Hawkins, R., Golub, S., Shau, H., Fahey, J.L., Popow, J., Robertson, P., Ahn, S. and Quinones, W. A comparative study of intravenous versus intralymphatic interleukin-2 with assessment of effects of interleukin-2 upon both peripheral blood and thoracic duct lymph. J. Immunotherapy. 1994; 15:140-146.

327. Liu, M., Fahey, J.L., Aziz, N., Cumberland, W., Skowron, G., Merigan, T. and the ACTG 047 Research Group. Zidovudine and dideoxycytidine differ in their effects on HIV-induced pathologic activation of the immune system. Journal of Infectious Diseases. 1994; 170:1165-1171.

328. Hofmann, B., Nishanian, P. and Fahey, J.L. HIV-gag p17 protein impairs proliferation of normal lymphocytes in vitro. AIDS. 1994; 8(7):1016-1017.

329. Watchi, R., Stiehm, E.R., Fahey, J.L., Stone, M., Deveikis, A., Frenkel, L., Aldrovandi, G., O’Rourke, S., Wei, L. and Bryson, Y.J. Neopterin is a better predictor of disease serverity than b2M in pediatric HIV infection. In: Pediatric AIDS and HIV Infection: Fetus to Adolescent. 1994; 5(4):226-231.

330. Naliboff, B.D., Solomon, G.F., Gilmore, S.L., Benton, D., Morley, J.E. and Fahey, J.L. The effects of the opiate antagonist naloxone on measures of cellular immunity during rest and brief psychological stress. J. of Psychosomatic Research. 1995; 39(3):345-359.

331. Wang, H., Nishanian, P. and Fahey, J.L. Characterization of immune suppression by a synthetic HIV gp41 peptide. Cellular Immunology. 1995; 161:236-243.

332. Graham, N.M.H., Park, L.P., Piantadosi, S., Phair, J.P., Mellors, J., Fahey, J.L. and Saah, A.J. Prognostic value of combined response markers among HIV-infected persons: A possible aid in the decision to change zidovudine monotherapy. Clinical Infectious Diseases. 1995; 20:352-362.

333. Hoover, D.R., Rinaldo, C., He, Y., Phair, J., Fahey, J.L. and Graham, N.M.H. Long-term survival without clinical AIDS after CD4+ cell counts fall below 200/mL. AIDS. 1995; 9:145-152.

334. Fahey, J.L. New advances on cytokines. Clinical Infectious Diseases. 1995.

335. Fahey, J.L. Clinical Immunology – A Distinct Area of Immunology, The Immunologist. 1995; 3(3):104-107.

336. Dezube, B.J., Lederman, M.M., Spritzler, J.G., Chapman, B., Korvick, J.A., Flexner, C., Dando, S., Mattiacci, M.R., Ahlers, C.M., Zhang, L., Novick, W.J., Kasdan, P., Fahey, J.L., Pardee, A.B., Crumpacker, C.S. and the NIAID AIDS Clinical Trials Group. High-dose pentoxifylline in patients with AIDS: Inhibition of TNF production. Journal of Infectious Diseases. 1995; 171:1628-632.

337. Fahey, J.L. Environmental exposures: Psychological stress. Human and Experimental Toxicology. 1995; 14:92-94.

338. Fahey, J.L. IUIS Clinical Immunology Committee. The Immunologist. 1995; 3(4):157-158.

339. Kemeny, M., Duran, R., Weiner, H., Taylor, S.E., Visscher, B. and Fahey, J.L. Immune system changes following the death of a partner in HIV seropositive gay men. Psychosomatic Medicine. 1995; 57:547-554.

340. Castle, S., Wilkins, S., Heck, E., Tanzy, K. and Fahey, J.L. Depression in care givers of demented patients is associated with altered immunity, impaired proliferative capacity, increased CD8+ and a decline in lymphocytes with surface signal transduction molecules (CD38+) and a cytotoxicity marker (CD56+CD8+). Clinical and Experimental Immunology. 1995; 101:487-493.

341. Fahey, J.L. and Mitsuyasu, R.T. Immunomodulatory approaches to the therapy of AIDS. Clinical Immunotherapeutics. 1996; 6(1):39-53.

342. Cole, S.W., Kemeny, M.E., Taylor, S.E., Visscher, B.R. and Fahey, J.L. Accelerated course of human immunodeficiency virus infection in gay men who conceal their homosexual identity. Psychosomatic Medicine. 1996; 58:219-231.

343. Breen, E.C., Derzic, S., Nguyen, T., Martinez-Maza, O. and Fahey, J.L. Cytokine changes central to the pathogenesis of HIV infection. HIV & Cytokines, Les Editions Inserm, M.Guenounou, editor. 1997; 147-154.

344. Breen, E.C., Salazar-Gonzalez, J.F., Shen, L.P., Kolberg, J.A., Urdea, M., Martinez-Maza, O. and Fahey, J.L. Circulating CD8 T cells show increased interferon-gamma (IFNg) mRNA expression in HIV infection. Cell. Immunol. 1997; 178:91-98.

345. Salazar-Gonzalez, J.F., Martinez-Maza, O., Aziz, N., Kolberg, J.A., Yeghiazarian, T., Shen, L-P. and Fahey, J.L. Relationship of plasma HIV-RNA levels and levels of TNFa and immune activation products in HIV infection. Clin. Immunol. Immunopathol. 1997; 84(1):36-45.

346. Bass, H.Z., Fahey, J.L., Nishanian, P., Detels, R., Cumberland, W., Kemeny, M. and Plaeger, S. Relation of impaired lymphocyte proliferative function to other major HIV-1 induced immunological changes. Clin. Diagn. Lab. Immunol. 1997; 4(1):64-69.

347. Shi, M., Taylor, J.M.G., Fahey, J.L., Hoover, D.R., Muñoz, A. and Kingsley, L.A. Early levels of CD4, neopterin and b2 microglobulin indicate future disease progression. J. Clin. Immunol. 1997; 17(1):43-52.

348. Jacobson, J.M., Greenspan, J.S., Spritzler, J., Ketter, N., Fahey, J.L. et al. Thalidomide for the treatment of oral aphthous ulcers in patients with Human Immunodeficiency Virus infection. New Engl. J. Med. 1997; 336:1487-1493.

349. Fahey, J.L. Clinical Immunology – A Distinct Area of Immunology. Russian J. Immunol. 1997; 2(1):4-8.

350. Solomon, G.F., Segerstrom, S.C., Grohr, P., Kemeny, M. and Fahey, J.L. Shaking up immunity: Psychological and immunologic changes following a natural disaster. Psychosomatic Medicine. 1997; 59:114-127.

351. Fahey, J.L. and Shin Flemmig, D. AIDS/HIV Reference Guide for Medical Professionals, 4th Edition, 556 pp. Williams & Wilkins, Baltimore, 1997.

352. Bower, J.E., Kemeny, M.E., Taylor, S.E., & Fahey, J.L. Cognitive processing, discovery of meaning, CD4 decline, and AIDS-related mortality among bereaved HIV-seropositive men. Journal of Consulting and Clinical Psychology. 1998; 66:979-986.

353. Segerstrom, S., Taylor, S., Kemeny, M. and Fahey, J.L. Optimism is associated with mood, coping and immune changes in response to stress. J. Pers. Soc. Psychol. 1998; 74(6): 1646-1655.

354. Segerstrom, S.C, Solomon, G.F., Kemeny, M.E., and Fahey, J.L. Relationship of worry to immune sequelae of the northridge earthquake. J. Behav. Med. 1998; 21(5):433-450.

355. Mandy, F.F., Bradley, J. and Fahey, J.L. International program for quality assurance and standardization for immunological measures relevant to HIV/AIDS: QASI program for CD4 proficiency testing. 12th World AIDS Conference, Geneva Switzerland. 1998 June 28-July 3.

356. Fahey, J.L., Taylor, J.M.G., Manna, B., Nishanian, P., Aziz, N., Giorgi, J.V. and Detels, R. Plasma immune activation marker levels compare favorably with and add to viral load and CD4 T cells as prognostic indicators for HIV/AIDS. 12th World AIDS Conference, Geneva Switzerland. 1998 June 28-July 3.

357. Fan, J., Nishanian, P., Breen, E.C., McDonald, M., and Fahey, J.L. Cytokine gene expression in normal human lymphocytes in response to stimulation. Clin. Diagn. Lab. Immunol. 1998; 5(3): 335-40.

358. Fahey, J.L. Cytokines, plasma immune activation markers and clinically relevant surrogate markers in Human Immunodeficiency Virus infection. Clin. Diagn. Lab. Immunol. 1998; 5: 597-603.

359. Fahey, J.L., Taylor, J.M.G., Manna, B., Nishanian, P., Aziz, N., Giorgi, J.V., and Detels, R. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T cell measurements. AIDS. 1998; 12: 1581-1590.

360. Cole, S.W., Korin, Y.D., Fahey, J.L., and Zack, J.A. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J. Immunol. 1998 Jul 15; 161(2):610-6.

361. Myers, L.W., Ellison, G.W., Merrill, J.E., El Hajjar, A., St. Pierre, B., Hijazin, M., Leake, B.D., Bentson, J., Nuwer, M.R., Tourtelotte, W., Davis, P., Granger, D. and Fahey, J.L. Pentoxifylline is not a promising treatment for Multiple Sclerosis in progression phase. Neurology. 1998; 51(5):1383-1486.

362. Nishanian, P., Taylor, J.M.G., Manna, B., Aziz, N., Grosser, S., Giorgi, J.V., Detels, R., and Fahey, J.L. Accelerated changes (inflection points) in levels of serum immune activation markers and CD4 and CD8 T cells prior to AIDS onset. J. AIDS. 1998; 18:162-170.

363. Nishanian, P., Aziz, N., Chung, J., Detels, R., and Fahey, J.L. Oral fluids as an alternative to serum for measurement of markers of immune activation. Clin. Diagn. Lab. Immunol. 1998 July; 507-512.

364. Salazar-Gonzalez, J.F., Martinez-Maza, O., Nishanian, P., Aziz, N., Shen, L-P., Grosser, S., Taylor, J.M.G., Detels, R., and Fahey, J.L. Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in HIV infection. J. Infect. Dis. 1998; 178:423-430.

365. Shen, L-P., Sheridan, P., Cao, W.W., Dailey, P.J., Salazar-Gonzalez, J.F., Breen, E.C., Fahey, J.L., Urdea, M.S., and Kolberg, J.A. Quantification of cytokine mRNA in peripheral blood mononuclear cells using branched DNA (bDNA) technology. J. Immunol. Methods. 1998; 215:123-134.

366. Fahey, J.L., Aziz, N., Nishanian, P. Reference standards and quality performance considerations for measurements of cytokines and soluble markers of immune activation. Clinical Immunology Newsletter. 1998; 18(7/8) 69-72.

367. Aziz, N., Nishanian, P., Fahey, J.L. Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: Quality control procedures. Clin. And Diagn. Lab. Immun. 1998; 5:755-761.

368. Plaeger, S., Bass, H.Z., Nishanian, P., Thomas, J., Aziz, N., Detels, R., King, J., Cumberland, W., Kemeny, M., and Fahey, J.L. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes. Clin. Immunology. 1999; 90(2): 238-246.

369. Aziz, N., Nishanian, P., Mitsuyasu, R., Detels, R., Fahey, J.L. Variables that effect assays for plasma cytokines and soluble activation markers. Clin. And Diagn. Lab. Immun. 1999; 6: 89-95.

370. Aziz, N., Mitsuyasu, R., Detels, R., Jacobson, J.M., Dezube, B.J., Lederman, M.M. and Fahey, J.L. Stability of plasma levels of cytokines and soluble activation markers in patients with HIV infection. J. Infect. Dis. 1999; 179:843-8.

371. Fahey, J.L. Clinical laboratory immunology: the future. Clin. Diagn. Lab. Immunol. 1999; 6(3):291-292.

372. Miller, G.E., Dopp, J.M., Myers, H.F., Felten, S.Y., and Fahey, J.L. Psychosocial predictors of natural killer cell mobilization during marital conflict. Health Psychology. 1999; 18(3):262-271.

373. Jacobson, J.M., Spritzler, J., Fox, L., Fahey, J.L., Jackson, J.B., Chernoff, M., Wohl, D.A., Wu, A.W., Hooten, T.M., Shea, B.E., Shikuma, C.M., McPhail, L.A., Simpson, D.M. and Traporell, C.B. Thalidomide for the treatment of esophageal aphthous ulcers in patients with Human Immunodeficiency Virus infection. The Journal of Infectious Diseases. 1999; 180(1):61-67.

374. Wilkins SS, Castle S, Heck E, Tanzy K and Fahey J. Immune Function, Mood, and Perceived Burden Among Caregivers Participating in a Psychoeducational Intervention. Psychiatr Serv. 1999 June; 50(6):747-749.

375. Sadeghi HM, Schnelle JF, Thomas JK, Nishanian P and Fahey,JL. Phenotypic and functional characteristics of circulating monocytes of elderly persons. Exp Gerontol. 1999; 34:959-970.

376. Fahey JL, Schnelle JF, Thomas JK, Gorre ME, Aziz N and Nishanian P. Distinct Categories of Immunologic Changes in Frail Elderly. Mech. Ageing Dev. 2000; 115:1-20.

377. Fahey JL, Aziz N, Spritzler J, Plaeger S, Nishanian P, Lathey JL, Landay AL, Schmitz JL, Wara DW, McElrath J, Douglas SD, Reuben J, Shearer WT, Nokta M, Polland R, Schooley R, Asthana D, Mizrachi Y, and Waxdal M. Need for an External Proficiency Testing Program for Cytokines, Chemokines and Plasma Markers of Immune Activation. Clin. And Diag. Lab. Immunology. 2000; 7(4):540-548.

378. Dopp J, Myers H, Miller G and Fahey JL. Increased natural killer-cell mobilization and cytotoxicity during marital conflict. Brain, Behavior and Immunity. 2000; 14:10-26.

379. Breen EC, McDonald M, Fan J, Boscardin J and Fahey JL. Cytokine gene expression occurs more rapidly in stimulated peripheral blood mononuclear cells from human immunodeficiency virus-infected persons. Clin. Diagn. Lab. Immunol. 2000; 7(5): 769-773.

380. Jacobson JM, Greenspan JS, Spritzler J, Fox L, Fahey JL, et al. Thalidomide in low intermittent doses does not prevent HIV-associated aphthous ulcer recurrence. J. Infectious Dis. 2001 Jan 15; 183(2):343-346.

381. Wilhelm M, Weissinger F, Kunzmann V, Muller JG and Fahey JL. Idiopathic CD4+ T Cell Lymphocytopenia Evolving to Monoclonal Immunoglobulins and Progressive Renal Damage Responsive to IL-2 Therapy. Clin. Immunology. 2001; 99(2):298-304.

382. Ironson G, Balbin E, Solomon G, Fahey JL, et al. Relative preservation of natural killer cell cytotoxicity and number in healthy AIDS patients with low CD4 counts. AIDS. 2001; 15:2065-2073.

383. Arora A, Fahey JL, and Seth P. DNA Vaccination for the Induction of Immune Responses against HIV-1 Subtype C Envelope Gene in Mice. Gene Ther. Mol. Biol. 2001; 6:79-89.

384. Sneed C, Chin D, Rotheram-Borus MJ, Milburn N, Murphy D, Corby N and Fahey JL. Test-Retest Reliability for Self-Reports of Sexual Behavior Among Thai and Korean Respondents. AIDS Education and Prevention. 2001; 13(4), 302-310.

385. Cole SW, Naliboff BD, Kemeny ME, Griswold MP, Fahey JL and Zack JA. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. PNAS. 2001 Oct; 98(22):12695-12700.

386. Bergeron M, Shafaie A, Ding T, Phaneuf S, Soucy N, Mandy F, Bradley J, and Fahey JL. Evaluation of Stabilized Blood Cell Products as Candidate Preparations for Quality Assessment Programs for CD4 T-cell Counting. Clinical Cytometry. 2002 April 15; 50(2):86-91.

387. Mandy F, Bergeron M, Houle G, Bradley J, and Fahey JL. The Impact of the International Program for Quality Assessment and Standardization for Immunological Measures Relevant to HIV/AIDS: QASI. Clinical Cytometry. 2002 April 15; 50(2):111-116.

388. Bower JE, Ganz PA, Aziz N, and Fahey JL. Fatigue and Proinflammatory Cytokine Activity in Breast Cancer Survivors. Psychosom Med. 2002 July-Aug; 64:604-611.

389. Nyamathi A, Robbins WA, Fahey JL, Wiley D, et al. Presence and Predictors of Hepatitis C Virus RNA in the Semen of Homeless Men. Biol Res Nurs. 2002 July; 4(1):22-30.

390. Kapasi ZF, Ouslander JG, Schnelle JF, Kutner M, and Fahey JL. Effects of an Exercise Intervention on Immunologic Parameters in Frail Elderly Nursing Home Residents. J Gerontol A Biol Med Sci. 2003 July; 58(7):M636-M643.

391. Bower JE, Kemeny ME, Taylor SE, Fahey JL. Finding Positive Meaning and Its Association with Natural Killer Cell Cytotoxicity Among Participants in a Bereavement-Related Disclosure Intervention. Ann Behav Med. 2003 Spring; 25(2):146-55.

392. Aziz N, Fahey JL, Detels R and Butch AW. Analytical Performance of a Highly Sensitive C-Reactive Protein-Based Immunoassay and the Effects of Laboratory Variables on Levels of CRP Protein in Blood. Clin Diagn Lab Immunol. 2003 July; 10(4):652-657.

393. Valdez H, Mitsuyasu R, Landay A, Sevin AD, Chan ES, Spritzler J, Kalams SA, Pollard RB, Fahey JL, et al. Interleukin-2 increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s. J Infect Dis. 2003; 187:320-325.

394. Nyamathi A, Fahey JL, Sands H and Casillas AM. Ebola Virus: Immune Mechanisms of Protection and Vaccine Development. Biological Research for Nursing. 2003 April; 4(4):276-281.

395. Thilakavathi S, Balasubramaniam MP, Newman PA, Sreevatsa, Ganapathy M, Boopathi K, Schilling RF, Fahey JL, et al.  Gender Differences in Sexual Risk Behaviours among STD Clinic Attendees, Government General Hospital, Chennai, India.  International Journal of STDs and AIDS.  2003 Jan-June; 24(1):14-19.

396. Bower JE, Ganz PA, Aziz N, Fahey JL.  T-Cell Homeostasis in Breast Cancer Survivors with Persistent Fatigue.  J Natl Cancer Inst.  2003 Aug 6; 95(15):1165-8.

397. Cole S, Kemeny ME, Fahey JL, Zack JA and Naliboff BD.  Psychological Risk Factors for HIV Pathogenesis: Mediation by the Autonomic Nervous System.  Biol Psychiatry.  2003 Dec 15; 54(12):1444‑56.

398. Dickerson SS, Kemeny ME, Aziz N, Kim KH, and Fahey JL.  Immunological Effects of Induced Shame and Guilt.  Psychosom Med.  2004; 66:124-131.

399. Mildvan D, Spritzler J, Grossberg SE, Fahey JL, Johnston DM, Schock BR, and Kagan J.  Serum Neopterin, an Immune Activation Marker, Independently Predicts Disease Progression in Advanced HIV-1 Infection.  Clinical Infectious Diseases.  2005 March 15; 40 (6):853-858.

400. Glover DA, Steele AC, Stuber ML and Fahey JL. Preliminary evidence for lymphocyte distribution differences at rest and after acute psychological stress in PTSD-symptomatic women. Brain Behav Immun 2005 May; 19(3):243-51.

401. Gruenewald T, Kemeny ME, Aziz N, and Fahey JL.  Acute Threat to the Social Self:  Shame, Social Self-Esteem and Cortisol Activity. Psychosom Med. 2004 Nov-Dec; 66(6):915-24.

402. Bower JE, Ganz PA, Dickereson SS, Petersen L, Aziz N, and Fahey JL.  Diurnal cortisol rhythm and fatigue in breast cancer survivors.  Psychoneuroendocrinology. 2005 Jan; 30(1):92-100.

403. Suhadev M, Nyamathi A, Swaminathan S, Venkatesan P, Sakthivel R, Shenbagavalli R, Suresh A, and Fahey JL. A Pilot Study on Willingness to Participate in Future Preventative HIV Vaccine Trails. Indian Journal of Medical Research, 2006; 124(6), 631-40.

404. Mitsuyasu R, Gelman R, Cherng DW, Landay A, Fahey JL et al.  The Virologic, Immunologic and Clinical Effects of Interleukin-2 with Potent Antiretroviral Therapy in Advanced Patients with HIV Infection: A Randomized Controlled Clinical Trial-ACTG328. Arch. Int Med. 2007; 167(6): 597-605.

405. Nyamathi A, Singh VP, Lowe A, Khurana A, Taneja D, George S, and Fahey JL. Knowledge and Attitudes about HIV/AIDS among Homeopathic Practitioners and Educators in India. ECAM. 2007; DO1:10.1093/ecam/nem018.

406. Nyamathi A, Vatsa M, Khaka DC, McNeese-Smith D, Leake B, and Fahey JL. HIV Knowledge Improvement amoung Nurses in India Using a Train-the-Trainer Program. JANAC. 2008; 19, 443-9.

407. Stapleton JT, Chaloner K, Zhang J, Klinzman D, Souza I, Xiang J, Landay A, Fahey JL, Pollard R, Mitsuyasu R. GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy. AIDS. 2009 Mar 13;23(5):605-10

408. Kabra SK, Mukherjee A, Vani SA, Sinha S, Sharma SK, Mitsuyasu R, Fahey JL. Continuing medical education on antiretroviral therapy in HIV/AIDS in India: needs assessment and impact on clinicians and allied health personnel. Natl Med J India. 2009 Sep-Oct;22(5):257-60.

409. Nyamathi A, Khurana A, Singh VP, Shriknth N, Taneja D, Choudhury SM, Shonali M, Fahey JL, and Nayak C. Delivery of a Model HIV Prevention and Health Promotion Train-the-Trainer Program in India by Homeopathy and Ayurveda Practitioners and Educators. World Medical & Health Policy. 2010; Vol. 2: Iss. 3, Article 4.

410. Fahey JL, Origin of CD4 T cell levels of 200 cells/µl as the key marker for AIDS diagnosis and therapy: was 186/µl more precise but less useful? AIDS. 2011 Jan 2;25(1):13-4.

411. Fahey JL, Clinical Immunology Society: the Early Years 1984-1989 : I. An Introduction. J Clin Immunol. 2011 Aug;31(4):533-6.  Clinical Immunology Society: the Early Years 1984-1989: See also, II. Preparations and Achievements. Posted on Clinical Immunology website: